Ani Pharmaceuticals (ANIP) Depreciation and Depletion (2012 - 2020)

Ani Pharmaceuticals (ANIP) has 9 years of Depreciation and Depletion data on file, last reported at $1.3 million in Q4 2020.

• For the quarter ending Q4 2020, Depreciation and Depletion rose 8.33% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2020 stood at $4.9 million (up 6.52% YoY), and the FY2025 full-year result was $8.9 million, up 20.27% from the prior year.
• Depreciation and Depletion climbed to $1.3 million in Q4 2020, from $1.2 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $1.3 million in Q4 2020 to a low of $200000.0 in Q1 2016.
• A 5-year average of $680000.0 and a median of $500000.0 in 2018 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion changed 0.0% in 2016 and jumped 300.0% in 2019, its largest moves.
• Tracing ANIP's Depreciation and Depletion over 5 years: stood at $200000.0 in 2016, then jumped by 50.0% to $300000.0 in 2017, then surged by 166.67% to $800000.0 in 2018, then jumped by 50.0% to $1.2 million in 2019, then rose by 8.33% to $1.3 million in 2020.
• Business Quant data shows ANIP's Depreciation and Depletion at $1.3 million in Q4 2020, $1.2 million in Q3 2020, and $1.2 million in Q2 2020.